Addressing the Negative Impact of Social Media on Body Image: An Online Randomized Controlled Pilot Trial
Abstract
Objective: Previous research has revealed negative effects of appearance-related social media content, such as fitspiration, on body satisfaction. However, specific interventions to reduce these detrimental effects are scarce. Therefore, this randomized controlled pilot trial investigated the efficacy of the four-week online intervention body image booster (BIBo), which aims to reduce the negative influence of social media on body image by addressing theoretically proposed underlying mechanisms.
Method: N = 157 female participants with elevated eating disorder (ED) symptoms were randomly allocated to the BIBo training or a waitlist control condition (WLC). The final sample included n = 38 completers in the BIBo training group and n = 46 completers in the WLC. Before and after the four training sessions, ED symptoms and reactivity to fitspiration content were assessed, as well as body dissatisfaction, social comparison processes, and internalization of body ideals.
Results: BIBo participants showed significant pre-post reductions in ED symptoms (d = -0.72) and reactivity to fitspiration content (d = -0.58), while WLC participants showed no significant change. The same pattern of results emerged for upward social comparison (d = -0.59), appearance comparison on social media (d = -0.89), body dissatisfaction (d = -0.40), and internalization of a thin body ideal (d = -0.42). There were no pre-post changes in internalization of muscularity or attractiveness ideals in either the…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 157 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.